VRK2 (NM 006296) Humaan Recombinant Proteïne

This gene encodes a member of the vaccinia-related kinase (VRK) family of serine/threonine protein kinases. The encoded protein acts as an effector of signaling pathways that regulate apoptosis and tumor cell growth. Variants in this gene have been associated with schizophrenia. Alternative splicing results in multiple transcript variants that differ in their subcellular localization and biological activity. [provided by RefSeq, Jan 2014]

Purified recombinant protein of Human vaccinia related kinase 2 (VRK2), transcript variant 1, Asp301-Asp486, with N-terminal His tag, expressed in E. coli, 50ug

Vaccinia-related kinase-2; vaccinia related kinase 2; vaccinia virus B1R-related kinase 2

7444

Q86Y07

NM_006296

2p16.1

E. coli

N-His

>50 ug/mL as determined by microplate BCA method

> 80% as determined by SDS-PAGE and Coomassie blue staining

Liquid

50mM Tris, 8M Urea, pH8.0

Druggable Genome, Protein Kinase, Transmembrane

21.2 kDa

Stable for 1 year at -20°C or below from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and opening the cap. For long-term storage, aliquot and store at -20°C or below. Avoid repeated freeze-thaw cycles.

VRK2

Human

NP_006287

https://www.ncbi.nlm.nih.gov/gene/7444

https://www.uniprot.org/uniprot/Q86Y07

https://www.ncbi.nlm.nih.gov/nuccore/NM_006296

https://www.ncbi.nlm.nih.gov/nuccore/NP_006287